Clinical study of 39 Chinese patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy

Ke-juan Ma1, Ning Li, Hong-tao Wang

  • 1Center for Arrhythmia Diagnosis and Treatment, Fu Wai Cardiovascular Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Insights

This study details the clinical and electrocardiogram features of Chinese patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). Implantable cardioverter-defibrillators (ICDs) offer protection, but ventricular tachycardia recurrence remains a challenge.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Genetic Heart Diseases

Background:

  • Limited studies exist on the clinical profile of Chinese patients diagnosed with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C).
  • Understanding ARVD/C in this population is crucial for accurate diagnosis and management.

Purpose of the Study:

  • To describe the clinical characteristics of ARVD/C patients from China.
  • To define the specific electrocardiogram (ECG) features in this cohort.
  • To evaluate treatment outcomes for ARVD/C in Chinese patients.

Main Methods:

  • Retrospective analysis of 39 ARVD/C patients hospitalized between 1998 and 2006.
  • Data collection from medical archives and follow-up records.

Main Results:

  • The majority of patients (33/39) were male, presenting at an average age of 34.9 years.
  • Common symptoms included palpitations (62%) and syncope (44%).
  • Key ECG findings were: QRSd >or= 110 ms (69%), epsilon wave (59%), QRSd ratio V(1-3)/V(4-6) >or= 1.2 (82%), T-wave inversions and S-wave upstroke in V(1-3) (96% and 90% in patients without RBBB).
  • Radiofrequency catheter ablation (RFCA) for ventricular tachycardia (VT) had a 68% success rate, but VT recurrence was 46% over 16.7 months.
  • Implantable cardioverter-defibrillators (ICDs) were effective, with all recipients receiving appropriate shocks.
  • One sudden cardiac death and one heart transplant occurred in patients treated with antiarrhythmic drugs alone.

Conclusions:

  • This study characterizes the clinical and ECG features of ARVD/C in a Chinese cohort.
  • ICDs provide essential protection against malignant arrhythmias in ARVD/C patients.
  • High recurrence rates of VT pose a significant challenge for RFCA therapy in ARVD/C management.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...